PhytoHealthTPE:4108 -0.83%72 Quick Ratio is 24.67 as of Dec. 2025, which is 12% above its 10-year median of 21.99. GuruFocus rates TPE:4108 with a GF Score™ of 72/100 and a GF Value™ of NT$15.95 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 997 Drug Manufacturers companies, PhytoHealth ranks better than 98.4% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. PhytoHealth's quick ratio for the quarter that ended in Dec. 2025 was 24.67.
PhytoHealth has a quick ratio of 24.67. It generally indicates good short-term financial strength.
The historical rank and industry rank for PhytoHealth's Quick Ratio or its related term are showing as below:
TPE:4108'
s Quick Ratio Range Over the Past 10 Years
Min: 8.48 Med: 21.99 Max: 26.94
Current: 24.67
During the past 13 years, PhytoHealth's highest Quick Ratio was 26.94. The lowest was 8.48. And the median was 21.99.
TPE:4108's Quick Ratio is ranked better than 98.4% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs TPE:4108: 24.67
PhytoHealth (TPE:4108) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
PhytoHealth Quick Ratio Related Terms
PhytoHealth Quick Ratio Historical Data
* Premium members only.
The historical data trend for PhytoHealth's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PhytoHealth's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PhytoHealth Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PhytoHealth's Quick Ratio distribution charts can be found below:
* The bar in red indicates where PhytoHealth's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
PhytoHealth's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PhytoHealth (TPE:4108) has a Quick Ratio of 24.67 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PhytoHealth and its competitors. This is 12% above median its historical median of 21.99. Over the past decade, PhytoHealth's Quick Ratio has ranged from 8.48 to 26.94. According to the industry distribution chart, PhytoHealth ranks #16 out of 997 companies in the Drug Manufacturers industry, placing it in the top 1.6%.
Is PhytoHealth's Quick Ratio too high?
PhytoHealth's current Quick Ratio of 24.67 is 12% above median its 10-year median of 21.99. Over the past 10 years, this metric has ranged from a low of 8.48 to a high of 26.94. The Drug Manufacturers industry median Quick Ratio is 1.45. PhytoHealth's value of 24.67 is 1601.4% above this industry median. Based on the distribution chart, PhytoHealth ranks #16 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PhytoHealth has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhytoHealth's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PhytoHealth ranks #16 out of 997 companies for Quick Ratio. This places PhytoHealth in the top 2% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. PhytoHealth's value of 24.67 is 1601.4% above this benchmark. Historically, PhytoHealth's own Quick Ratio has ranged from 8.48 to 26.94 over the past decade. While the company's 10-year median is 21.99 vs. the industry median of 1.45, PhytoHealth has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PhytoHealth's current Quick Ratio of 24.67 is 1601.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PhytoHealth and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhytoHealth's current Quick Ratio is 24.67, which is 12% above median its own 10-year median of 21.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhytoHealth stock overvalued right now?
Based on GuruFocus' analysis, PhytoHealth (TPE:4108) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$15.95, compared to a current price of NT$12.00 — trading 24.8% below its estimated fair value. The current Quick Ratio is 24.67, which is 12% above median its 10-year median of 21.99 and 1601.4% above the Drug Manufacturers industry median of 1.45. PhytoHealth's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For PhytoHealth (TPE:4108), the current Quick Ratio is 24.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PhytoHealth (TPE:4108) Overvalued in 2026?
Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued.
The current stock price of NT$12.00 is trading 24.8% below its estimated GF Value™ of NT$15.95.
GuruFocus considers PhytoHealth to be Modestly Undervalued.
Key valuation signals for TPE:4108:
Quick Ratio: 24.67 (12% above median its 10-year median of 21.99)
GF Value™: NT$15.95 vs. price of NT$12.00 (24.8% below fair value)
Industry Position: 1601.4% above the Drug Manufacturers median (#16 of 997)
No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
72GF Score
Get the complete analysis for TPE:4108
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4108 has been successfully added to your 
